Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Zimmer Celebrates Key Milestones For NexGen Complete Knee System
By: PR Newswire Association LLC. - 27 Mar 2015Back to overview list

LAS VEGAS, March 27, 2015 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) is celebrating a key milestone in 2015 for its NexGen® Complete Knee System.

 

2015 is the 20th year since Zimmer first introduced the NexGen knee system, with its innovative design and component quality, to the market. To date, more than five million implantations of the NexGen knee have taken place worldwide.

"The 20 year history of the NexGen knee demonstrates the importance of design innovation and component quality for surgeons and patients alike," said Brad Quick, Vice President, Knee Marketing.  "By offering Minimally Invasive Solutions™ instrumentation, accommodating safe flexion and restoring natural kinematics, the NexGen knee has been – and will continue to be – a significant move forward in knee replacement."

About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2014 sales were approximately $4.7 billion.  The Company is supported by the efforts of more than 9,000 employees worldwide.  More information about Zimmer is available at www.zimmer.com.

Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Such statements are based upon the current beliefs and expectations of Zimmer's management and are subject to significant risks and uncertainties that could cause actual outcomes and results to differ materially.  These risks and uncertainties include, but are not limited to: future test results or patient experiences being inconsistent with test findings to date; actions of regulatory bodies or other governmental authorities; changes in laws and regulations; competitive developments; and other risks and uncertainties described in Zimmer's periodic reports filed with the U.S. Securities and Exchange Commission.  Zimmer disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in Zimmer's periodic reports.  Readers of this communication are cautioned not to place undue reliance on these forward-looking statements, since, while management believes the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.

Logo - http://photos.prnewswire.com/prnh/20131216/MM33947LOGO

SOURCE Zimmer Holdings, Inc.

Related companies:Zimmer Biomet
Copyright 2015 PR Newswire Association LLC. Back to overview list
to the top ↑